1,785
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

, , , , , , & show all
Pages 1507-1517 | Received 05 Dec 2014, Accepted 11 Mar 2015, Published online: 18 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Timo Vesikari, Jerzy Brzostek, Anitta Ahonen, Marita Paassilta, Ewa Majda-Stanislawska, Leszek Szenborn, Miia Virta, Robert Clifford, Teresa Jackowska, Murray Kimmel, Ilaria Bindi, Pavitra Keshavan, Paola Pedotti & Daniela Toneatto. (2021) Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents. Human Vaccines & Immunotherapeutics 17:11, pages 4689-4700.
Read now
Federico Martinón-Torres, Lidia Serra & Marco Aurelio P. Safadi. (2020) Protecting the most vulnerable age group: a review of MenACWY-TT immunogenicity and safety in infants. Expert Review of Vaccines 19:4, pages 313-325.
Read now
Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan & Daniela Toneatto. (2018) Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Human Vaccines & Immunotherapeutics 14:5, pages 1161-1174.
Read now

Articles from other publishers (18)

Markus Knuf. (2023) Was gibt es Neues bei der Meningokokken- und Pneumokokken-Impfung?. Kinder- und Jugendmedizin 23:03, pages 165-180.
Crossref
Rafik Bekkat-Berkani, Elena Fragapane, Scott Preiss, Rino Rappuoli, Woo-Yun Sohn, Lamine Soumahoro & Kumaran Vadivelu. (2022) Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Journal of Infection 85:5, pages 481-491.
Crossref
Francesca Rech, Riccardo De Ricco, Sara Giannini, Luca Nompari, Marilena Paludi, Stefania Berti, Chiara Parlati, Simona Cianetti & Francesco Berti. (2022) Glycoconjugate content quantification to assess vaccine potency: A simplified approach. Biologicals 76, pages 10-14.
Crossref
Mark R. Alderson, Peter D. Arkwright, Xilian Bai, Steve Black, Ray Borrow, Dominique A. Caugant, Ener Cagri Dinleyici, Lee H. Harrison, Jay Lucidarme, Lucy A. McNamara, Susan Meiring, Marco A.P. Sáfadi, Zhujun Shao, David S. Stephens, Muhamed-Kheir Taha, Julio Vazquez, Bingqing Zhu & GMI collaborators. (2022) Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review. Journal of Infection 84:3, pages 289-296.
Crossref
Jiří Beran, Daniel Dražan, Igwebuike Enweonye, Chiranjiwi Bhusal & Daniela Toneatto. (2021) Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults. mSphere 6:6.
Crossref
M. Knuf & T. Tenenbaum. (2021) MeningokokkenimpfstoffeMeningococcal vaccines. Monatsschrift Kinderheilkunde 169:11, pages 1034-1042.
Crossref
Jaime Fergie, Ashley Howard, Liping Huang & Amit Srivastava. (2021) Implementation Experience With Meningococcal Serogroup B Vaccines in the United States. Pediatric Infectious Disease Journal 40:3, pages 269-275.
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Rodolfo Villena & Magdalena Bastías. (2020) Priorización de nuevas vacunas e innovación al servicio de estrategias de vacunación. Revista Médica Clínica Las Condes 31:3, pages 343-351.
Crossref
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams & Lidia Serra. (2019) Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review. Infectious Diseases and Therapy 8:3, pages 307-333.
Crossref
Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine 36:50, pages 7609-7617.
Crossref
Jo Anne Welsch, Shelly Senders, Brandon Essink, Thomas Klein, Igor Smolenov, Paola Pedotti, Silvia Barbi, Bikash Verma & Daniela Toneatto. (2018) Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study. Vaccine 36:35, pages 5309-5317.
Crossref
Leszek Szenborn, Stan L. Block, Teresa Jackowska, Ryszard Konior, Diego D’Agostino, Igor Smolenov, Daniela Toneatto & Jo Anne Welsch. (2018) Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines. Pediatric Infectious Disease Journal 37:5, pages 475-482.
Crossref
Maria Elena Flacco, Lamberto Manzoli, Annalisa Rosso, Carolina Marzuillo, Mauro Bergamini, Armando Stefanati, Rosario Cultrera, Paolo Villari, Walter Ricciardi, John P A Ioannidis & Despina G Contopoulos-Ioannidis. (2018) Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. The Lancet Infectious Diseases 18:4, pages 461-472.
Crossref
Francesco Berti. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic 123 137 .
Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2018. Plotkin's Vaccines. Plotkin's Vaccines 644 662.e6 .
Robert C. Read, Peter Dull, Xilian Bai, Kate Nolan, Jamie Findlow, Rohit Bazaz, Annett Kleinschmidt, Maggie McCarthy, Huajun Wang, Daniela Toneatto & Ray Borrow. (2017) A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine. Vaccine 35:3, pages 427-434.
Crossref
Esther Benamu & José G. Montoya. (2016) Infections associated with the use of eculizumab. Current Opinion in Infectious Diseases 29:4, pages 319-329.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.